Subtitle
Medical journal publishes study comparing accuracy of different blood tests used to track moderate chronic kidney disease in adults.
The BMJ has published new research examining how accurately different blood test methods can monitor kidney function in adults with moderate chronic kidney disease, according to a post on the medical journal’s official social media account.
What the Research Covers
The study focuses on glomerular filtration rate estimation, a key measurement doctors use to assess how well kidneys are filtering waste from the blood. The research compares two different approaches: tests based on creatinine levels alone versus those that combine creatinine with cystatin C measurements.
Both creatinine and cystatin C are substances that healthy kidneys normally filter out of the blood. When kidney function declines, levels of these markers rise in the bloodstream. Medical professionals use these measurements to calculate estimated glomerular filtration rate, which helps determine the stage and progression of chronic kidney disease.
Why Testing Accuracy Matters
Chronic kidney disease affects millions of adults across the UK, with many cases going undiagnosed until the condition reaches advanced stages. The disease progresses through five stages, with moderate chronic kidney disease typically referring to stages 3A and 3B, where kidney function has declined to between 30-59% of normal capacity.
Accurate monitoring becomes essential at these stages. Patients need regular blood tests to track whether their condition is stable, improving, or worsening. The precision of these measurements influences treatment decisions, medication dosing, and referral timing to specialist kidney services.
Current Testing Landscape
NHS laboratories currently use various methods to estimate kidney function, with most relying primarily on creatinine-based calculations. However, factors like muscle mass, age, and ethnicity can affect creatinine levels independently of kidney function, potentially leading to less accurate results in some patients.
Cystatin C testing, as available, is used less frequently due to higher costs compared to standard creatinine tests. The protein is produced by all cells in the body at a relatively constant rate and is less affected by muscle mass variations.
Source: @bmj_latest
Key Takeaways
- BMJ has published research comparing kidney function testing methods for chronic disease monitoring
- Study examines creatinine-only tests versus combined creatinine and cystatin C measurements
- Research focuses specifically on adults with moderate chronic kidney disease
What This Means for Kent Residents
Kent residents with chronic kidney disease receive regular monitoring through their GP surgeries and local NHS trusts, with testing protocols following national guidelines. Any changes to recommended testing methods based on this research would be implemented through NHS England guidance to ensure consistent care across the county. Patients concerned about their kidney function should continue following their current monitoring schedule and discuss any questions about their blood test results with their GP or kidney specialist team.